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Summary
The RTK-Ras-ERK cascade is a central signaling mod-
ule implicated in the control of diverse biological pro-
cesses including cell proliferation, differentiation, and
survival. The coupling of RTK to Ras is mediated by
the Ras-specific nucleotide-exchange factor Son of
Sevenless (Sos), which activates Ras by inducing the
exchange of GDP for GTP [1]. Considerable evidence
indicates that the duration and amplitude of Ras sig-
nals are important determinants in controlling the bio-
logical outcome [2]. However, the mechanisms that
regulate the quantitative output of Ras signaling re-
main poorly understood. We define a previously un-
recognized regulatory component of the machinery
that specifies the kinetic properties of signals propa-
gated through the RTK-Ras-ERK cascade. We demon-
strate that the establishment of a positive feedback
loop involving RasGTP and Sos leads to an increase
in the amplitude and duration of Ras activation in re-
sponse to EGF stimulation. This effect is propagated
to downstream elements of the pathway as reflected
by sustained EGF-induced ERK phosphorylation and
enhanced SRE-dependent transcription. As a conse-
quence, the physiological endpoint of EGF action is
switched from proliferation to differentiation. We pro-
pose that the engagement of Ras/Sos positive feed-
back loop may contribute to the mechanism by which
ligand stimulation is coupled to discrete biological
responses.
*Correspondence: dafna.bar-sagi@med.nyu.eduResults and Discussion
Recent structure-function analyses of Sos have led to
the identification of a previously unrecognized regu-
lation mode of Sos-mediated guanine nucleotide
exchange on Ras. In addition to its well characterized
catalytic site which upon binding of nucleotide-loaded
Ras promotes nucleotide displacement, Sos possesses
a second Ras binding site that is distal to the catalytic
site and interacts with nucleotide-bound Ras [3]. This in-
teraction results in an increased affinity for Ras at the
catalytic site and an increase in the enzymatic activity
of Sos. Though both GDP- and GTP-bound Ras can al-
losterically stimulate Sos, GTP-bound Ras does so 10-
fold more potently [4]. Because RasGTP is the product
of the Ras-Sos exchange reaction in vivo, we have pos-
tulated that this allosteric effect may constitute a posi-
tive feedback mechanism for Ras activation where the
product of the exchange reaction contributes to its fur-
ther acceleration. In support of this idea, we have previ-
ously shown that Sos activity, both in vivo and in vitro,
is greatly reduced when the binding of Ras to the distal
site is compromised [4].
In an effort to further explore the functional signifi-
cance of the allosteric regulation of Sos by RasGTP,
we have sought to develop an experimental strategy
that will permit the manipulation of Sos activity via the
distal site in vivo. We have reasoned that this could be
achieved by introducing into cells a Ras mutant that se-
lectively interacts with the distal site. By necessity, such
a mutant would have to display the following properties:
(1) constitutive binding to GTP, (2) capacity to allosteri-
cally stimulate the exchange activity of Sos, and (3) a de-
fect in downstream signaling. The third property would
be critical for the ability to monitor Ras-dependent sig-
nals that are generated selectively through Ras that
has been activated via Sos-mediated catalysis (Fig-
ure 1A). We have previously characterized a mutant of
HRas, HRas A59G (hereafter referred to as Ras A59G),
that displays two of these three properties, namely con-
stitutive binding to GTP because of an impaired GTPase
activity and the capacity to allosterically stimulate Sos
[3, 5]. Moreover, when bound to GTP, this mutant is de-
fective in Sos-mediated exchange and thus makes it
a highly effective allosteric modulator of Sos [5, 6] (see
Figure S1A in the Supplemental Data available with
this article online).
By using Ras A59G as a template, we have searched
for an intragenic mutation that would abrogate the
Raf-1 effector interaction that is necessary for signaling
through the ERK cascade without affecting Ras’s ability
to allosterically stimulate Sos activity. An aspartic acid
at position 38 of Ras has been implicated in mediating
interactions with Raf-1 [7, 8]. As illustrated in Figure 1B,
substitution of this aspartic-acid residue with glutamic
acid (Ras A59G,D38E) resulted in a 100-fold decrease
in Raf-1 binding in vitro. This mutation did not alter the
guanine nucleotide exchange and GTPase activities of
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2174Figure 1. Biochemical Characteristics of Ras A59G,D38E
(A) A schematic illustration of the experimental design. The guanine-nucleotide-exchange activity of Sos is mediated by two structural elements:
the Ras exchange motif (Rem) and the Cdc25 domain [25]. The catalytic site of Sos is contained within the Cdc25 domain. Allosteric regulation of
Sos occurs through the distal site that is formed by the Rem and Cdc25 domain. A Ras mutant (green) that binds preferentially to the distal site of
Sos is used to determine how allosteric modulation of Sos affects Ras signaling.
(B) Ras A59G,D38E has reduced affinity for the Ras binding domain (RBD) of Raf. An in vitro GST-Raf-RBD pull-down assay was performed with
purified Ras A59G or Ras A59G,D38E loaded with 32P-labeled GTP as described in the Supplemental Experimental Procedures. The GST-Raf-
RBD was immobilized on glutathione agarose and incubated with indicated concentrations of Ras. At the end of the incubation period, the beads
were washed and bound radioactivity was measured by scintillation counting.
(C) Ras A59G,D38EGTP enhances Sos-Cat-catalyzed nucleotide-exchange activity. Comparison of intrinsic and Sos-Cat (1 mM)-catalyzed nu-
cleotide exchange of mant-GDP for cold GDP from RasWT (1 mM) in the presence of stoichiometric amounts of either Ras A59G loaded with GTP
or Ras A59G,D38E loaded with GTP or GDP. Nucleotide-exchange reactions were conducted as described in Supplemental Experimental
Procedures. Rates were fitted to single exponentials. For (B) and (C), the results shown are representative of three independent experiments.
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2175Ras A59G (Figures S1A–S1C). To test the capacity of
Ras A59G,D38E to allosterically enhance Sos activity,
we performed in vitro nucleotide-exchange assays
by using the catalytic domain of Sos, hereafter referred
to as Sos Cat. This domain spans residues 564–1049
and encompassed both the catalytic and distal Ras-
binding sites. The rate of Sos-Cat-catalyzed nucleotide
dissociation was significantly enhanced by Ras
A59G,D38EGTP to the same extent as the acceleration
of nucleotide exchange observed with Ras A59G
(Figure 1C). That this effect is exerted through the inter-
action of Ras A59G, D38EGTP with the distal site is in-
dicated by the fact that the GDP-bound form of Ras
A59G,D38E had no affect on the kinetics of the ex-
change reaction under the conditions used here. To-
gether, these results indicate that the D38E mutation
does not interfere with Ras-mediated allosteric regula-
tion of Sos. This conclusion is in agreement with struc-
tural data showing that aspartic acid 38 is not engaged
in interactions that are critical for the binding of Ras to
the distal site [3].
To ascertain that the biochemical properties of Ras
A59G,D38E displayed in vitro are maintained in vivo,
we first monitored by thin-layer chromatography the nu-
cleotide-binding status of Ras A59G,D38E isolated from
serum-starved cells. As illustrated in Figure 2A, we have
found that Ras A59G,D38E exists in the cell predomi-
nantly in a GTP-bound form. To determine whether
Ras A59G,D38E can enhance Sos activity in vivo
through an interaction with the distal site, we cotrans-
fected serum starved cells with Sos Cat and Ras
A59G,D38E and used the phosphorylation of ERK mito-
gen-activated protein kinase (MAPK) as a readout for
Ras activation [9, 10]. It should be noted that for these
experiments, the levels of ectopically expressed Sos
Cat were titrated down so that the detection of a poten-
tiating effect could be facilitated. As demonstrated in
Figure 2B, the expression of Ras A59G,D38E alone had
no effect on ERK activation, consistent with the loss
of Raf-1 binding observed for this mutant in vitro
(Figure 1B). In contrast, in the presence of Sos Cat, the
expression of Ras A59G,D38E led to an increase in
ERK MAPK activation. The increase was abolished
when Ras A59G,D38E was coexpressed with a previ-
ously characterized Sos Cat mutant that contains dis-
tal-site substitutions (Sos Cat L687E/R688A), which in-
hibit the binding of RasGTP [4]. These data indicate
that Ras A59G,D38E enhances Sos activity in a manner
that is dependent on the distal site. Hence, we refer to
this mutant from here on as Enhancer Ras. Given that
the occupation of the distal site by RasGTP mediates
the formation of a positive feedback loop for Sos-
dependent Ras activation, Enhancer Ras provides a
means by which the function of such a feedback loop
can be assessed in vivo.
It is well documented that in response to growth-fac-
tor stimulation, Ras undergoes a transient activation,
the kinetics of which is growth-factor and cell-type de-
pendent [11]. To investigate the effects of Enhancer Ras
on growth factor-induced Ras activation, we cotrans-
fected HeLa cells with HA-tagged wild-type Ras with
or without T7-tagged Enhancer Ras, and measured the
activation of Ras after epidermal growth-factor (EGF)
stimulation by using a Raf-Ras-binding domain (RBD)Figure 2. Biochemical Properties of Ras A59G,D38E In Vivo
(A) Ras A59G,D38E is constitutively active in serum-starved COS1
cells. COS1 cells were transfected with the indicated Ras expression
vectors. The cells were serum-starved and labeled with [32P]ortho-
phosphate, and the guanine nucleotide content of the Ras proteins
was analyzed by thin-layer chromatography as described previously
[26]. The result is representative of two independent experiments.
(B) Ras A59G,D38E enhances Sos Cat activity in vivo. COS1 cells
were cotransfected with HA-tagged ERK MAP kinase and the indi-
cated constructs. The cells were subsequently serum-starved and
ERK activation was determined by immunecomplex kinase assay
as previously described [4]. Results shown represent the averages
of four independent experiments. Error bars represent the standard
deviations. *p < 0.05 (AU; arbitrary units).
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2176Figure 3. Allosteric Stimulation of Sos Influences the Kinetics of EGF-Induced Ras Activation
(A) Expression of Enhancer Ras results in an increased amplitude and duration of Ras activation in response to EGF. HeLa cells were cotrans-
fected with HA-tagged RasWT and either T7-Enhancer Ras or Mock Ras. The cells were serum-starved and stimulated with EGF for the indicated
intervals. The levels of GTP-bound RasWT were determined by pull-down assay with GST-Raf RBD as described in the Supplemental Experi-
mental Procedures. The levels of activated RasWT were quantified by densitometry scanning and normalized to the levels of total RasWT.
Results shown represent the averages of three independent experiments. Error bars represent the standard deviations. (AU; arbitrary units).
(B) Knockdown of Sos 1 and 2 by RNA interference. HeLa cells were transfected with pSuper vector containing Blasticidin resistance marker and
targeting sequences for Sos 1 and 2 or scramble sequence. The cells were selected with Blasticidin prior to lysis. The levels of Sos were deter-
mined by immunoblotting of whole-cell lysate with an antibody that recognizes both Sos 1 and 2.
(C) The potentiation of Ras activation by Enhancer Ras is mediated by Sos. HeLa cells were cotransfected with indicated T7-tagged Ras con-
structs and HA-tagged RasWT along with pSuper constructs containing the Blasticidin resistance marker and the indicated target sequences.
After selection with Blasticidin, the cells were serum-starved and then stimulated with EGF for the indicated intervals and lysed. The level of
RasWT activation was determined as described in (A). For (B) and (C), the experiment shown is representative of three independent experiments.pull-down assay [12]. As a control (Mock Ras), we have
used a T7-tagged HRas mutant, HRas G12V,T35A,
which is defective in effector interactions as well as in
the ability to stimulate Sos catalytic activity (data not
shown [13, 14]). Consistent with earlier studies, we
have found that the levels of active Ras reached
a peak within 10 min of EGF stimulation and declined
to basal levels by 20 min (Figure 3A) [11]. In the presence
of Enhancer Ras, Ras activation was approximately 3-
fold higher, reached maximum within 5 min of EGF stim-
ulation and remained at this level for up to 20 min
(Figure 3A), and ultimately subsided at 40 min after stim-
ulation (data not shown). These observations indicate
that the kinetics of EGF-induced Ras activation can be
modulated by Enhancer Ras both with respect to ampli-
tude and duration.
To demonstrate that the effects of Enhancer Ras are
mediated through its interaction with Sos, we have per-
formed the same experiment by using HeLa cells in
which Sos protein expression was knocked down by
RNA interference (RNAi). As illustrated in Figure 3B,
the target sequence we have used resulted in a
significant suppression (>85%) of the expression of
both human Sos proteins (Sos1 and Sos2). Under theseconditions, EGF-induced activation of Ras in the pres-
ence or absence of Enhancer Ras was abolished, indi-
cating that the function of Enhancer Ras is Sos depen-
dent (Figure 3C). It is of interest to note that the
potentiating effect of Enhancer Ras is manifested only
in the presence of EGF. This is likely because Sos re-
mains autoinhibited in the absence of growth-factor sig-
naling. The autoinhibited state of Sos has been shown to
be conferred by the interaction of the Dbl homology (DH)
domain of Sos with the distal site, and such interaction
occludes the binding of Ras to this site [4]. The molecu-
lar mechanism mediating the relief of Sos autoinhibition
remains to be established.
The Ras to ERK MAPK signaling cascade plays a cen-
tral role in mediating a wide spectrum of receptor tyro-
sine kinase (RTK)-dependent cellular responses [15].
To assess whether the engagement of the distal site of
Sos affects Ras to ERK MAPK signaling, we cotrans-
fected HeLa cells with HA-tagged ERK and T7-tagged
Enhancer Ras or Mock Ras as a control. ERK MAPK
activation in response to EGF stimulation was monitored
by probing of HA immunoprecipitates with phosphoryla-
tion-specific anti-ERK MAPK antibodies. Expression of
Enhancer Ras resulted in a significant increase in the
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2177Figure 4. Contribution of Allosteric Stimulation of Sos to Signal-Transduction Events Downstream of Ras
(A) Expression of Enhancer Ras results in an increase in amplitude and duration of EGF-induced ERK MAP kinase activation. HeLa cells were
cotransfected with the indicated T7-tagged Ras and HA-tagged ERK MAP kinase constructs. The cells were serum-starved and stimulated
with EGF for the indicated intervals. ERK MAP kinase activation was determined by HA immunoprecipitation followed by immunoblotting
with antibodies specific for ERK2 and phosphorylated ERK1/2 as described in the Supplemental Experimental Procedures. The levels of ERK
activation, as represented by ERK phosphorylation, was quantified by densitometry and normalized to levels of total ERK2. The experiment
shown is representative of three independent experiments. (AU; arbitrary units).
(B) Expression of Enhancer Ras sensitizes cells to growth-factor-induced transcriptional activation. HeLa cells were cotransfected with the in-
dicated Ras constructs, SRE-Luciferase and CMV-b-Galactosidase (b-Gal). The cells were serum-starved and stimulated with the indicated
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sponse to EGF compared with that in control cells
(Figure 4A). RNAi-mediated knockdown of Sos resulted
in an abrogation of EGF-induced ERK MAPK activation
in the presence of Enhancer Ras (Figure S2), indicating
that similarly to its effect on Ras activation, the effect
of Enhancer Ras on ERK activation is Sos dependent.
Collectively, these results implicate the distal site of
Sos in the regulation of the dynamics of Ras signaling.
The conversion of transient activation of signaling
pathways to long-term changes in cellular behavior is
accomplished through changes in gene-expression pat-
terns [16]. The serum response element (SRE) is a well-
established transcriptional target of the Ras to ERK
MAPK cascade [17]. To examine whether the transcrip-
tional upregulation of SRE is influenced by the allosteric
modulation of Sos, we cotransfected HeLa cells with ei-
ther Mock or Enhancer Ras along with SRE-Luciferase
and CMV-b-Galactosidase (b-Gal) and assayed them
for the induction of luciferase activity in response to
increasing concentrations of EGF. As shown in Fig-
ure 4B, SRE activity in response to EGF was augmented
in cells expressing Enhancer Ras relative to cells ex-
pressing Mock Ras. Collectively, the potentiating effects
of Enhancer Ras on EGF-induced Ras activation, ERK
phosphorylation and SRE-dependent transcription
indicate a role for Sos-mediated positive feedback of
Ras activation in dictating the signaling output of the
Ras pathway.
It has been shown that differences in the kinetics of
ERK activation can be coupled to specific biological out-
comes. For example, in PC12 cells, nerve growth factor
(NGF) induces sustained activation of ERK and pro-
motes differentiation into sympathetic-like neurons. In
contrast, EGF induces transient ERK activation and
cell proliferation [16]. Because EGF-induced ERK acti-
vation is prolonged in the presence of Enhancer Ras
(Figure 4A), PC12 cell differentiation provides an effec-
tive experimental system for assessment of the extent
to which Sos-mediated positive feedback regulation of
Ras can contribute to the specification of a physiological
process. To address this question, we cotransfected
PC12 cells with T7-tagged Enhancer Ras or Mock Ras
and treated them with EGF for 72 hr. Cells expressing
T7-tagged Ras were detected by indirect immunofluo-
rescence, and differentiation was assessed by visualiza-
tion of neurite extension. As illustrated in Figure 4C, 60%
of the Enhancer Ras expressing cells underwent differ-
entiation, whereas the same treatment had no effect
on cells expressing Mock Ras. Consistent with this ef-
fect, the expression of Enhancer Ras led to an increasein the intensity and duration of EGF-induced Ras and
ERK activation (Figure 4D and Figure S3). The Mock
Ras expressing cells retained the ability to undergo dif-
ferentiation in response to NGF (data not shown). Thus,
the catalytic potential of Sos may be an important deter-
minant in specifying discrete cellular responses. It
should be noted that the present study has relied pri-
marily on ectopic-expression approaches to manipulate
Sos activity. The development of pharmacological tools
that target specific elements of the Sos-mediated ex-
change reaction in vivo may provide further insights
into the link between the output of this reaction and
the physiological outcome.
Several mechanisms have been implicated in the reg-
ulation of the temporal pattern of ligand-induced activa-
tion of the Ras to ERK cascade in mammalian cells.
These include the differential recruitment of adaptor
molecules to activated receptors [18–20] as well as dif-
ferences in the surface density or intracellular trafficking
fate of receptors [21]. In addition, a positive feedback
loop between ERK and PKC signaling and a negative
feedback loop set up by the transcriptional upregulation
of Sprouty have been shown to influence the dynamic of
the Ras to ERK cascade [22, 23]. The findings presented
in this study identify Sos as a participant in the regula-
tory network that controls the quantitative output of
the Ras pathway. The role of Sos in this context depends
on its interaction with the product of the reaction it cat-
alyzes, RasGTP, and the positive feedback loop that is
generated by this interaction can prolong and amplify
the response to a signal. Positive feedback is a key
regulatory modality by which signaling systems are ki-
netically shaped with respect to bistability, inducibility,
and resistance to noise [24]. The placement of such reg-
ulatory mechanism at the apex of the Ras signaling cas-
cade may serve to ensure that the functional output of
the pathway is aligned with a context-mandated cellular
response.
Supplemental Data
Supplemental Data include Experimental Procedures and three fig-
ures and can be found with this article online at http://www.
current-biology.com/cgi/content/full/16/21/2173/DC1/.
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